Diabetes Mellitus: all 11,089 studies
Page 102 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic GastroparesisCompletedNCT00612014Phase 2
- Self-Managed Walking Improves FunctionCompletedNCT00611988Phase 2
- Efficacy and Safety Study of Sulfonylureas in Neonatal Diabetes MellitusCompletedNCT00610038Phase 2
- The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning DosingCompletedNCT00609895Phase 4
- Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 DiabetesCompletedNCT00609856Phase 4
- Effect of Amount and Type of Dietary Carbohydrates on Risk for Cardiovascular Heart Disease and DiabetesCompletedNCT00608049Not applicable
- First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050CompletedNCT00607906Phase 1
- Applications Site Reactions After Injection of Insulin Detemir and Saline in Subjects With DiabetesCompletedNCT00607737Phase 4
- A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 DiabetesCompletedNCT00607503Phase 1
- Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I DiabeticsCompletedNCT00607230Phase 1
- A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic VolunteersCompletedNCT00606112Phase 1
- UVA Islet Cell Transplantation in Patients With Type I DiabetesStatus unknownNCT00605592Phase 1
- Safety of Insulin Detemir in Children With Type 1 DiabetesCompletedNCT00605137Phase 3
- Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 DiabetesCompletedNCT00605111Phase 4
- Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00605020Phase 3
- Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 DiabetesCompletedNCT00604656Phase 3
- Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 DiabetesCompletedNCT00604396Phase 3
- Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring DiabetesCompletedNCT00604344Phase 3
- Efficacy and Safety of Insulin Detemir in Type 2 Diabetes Inadequately Controlled on OHA Therapy AloneCompletedNCT00604253Phase 3
- Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes MellitusCompletedNCT00603031Not applicable
- Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 DiabetesCompletedNCT00600626Phase 3
- Efficacy and Safety of Biphasic Insulin Aspart 30 FlexPen® in Insulin Naive Subjects With Type 2 DiabetesCompletedNCT00600366Phase 4
- HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican PopulationWithdrawnNCT00600236Phase 3
- The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans)CompletedNCT00599040Phase 4
- Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD TherapyCompletedNCT00598793Phase 3
- Effect of Fenugreek on Blood Sugar and Insulin in Diabetic HumansCompletedNCT00597350
- Human Insulin NPH and Insulin Aspart in Type 1 DiabetesCompletedNCT00597233Phase 4
- Surgical Treatment of Type 2 Diabetes in Non-Morbidly Obese PatientsWithdrawnNCT00596973Phase 4
- Comparative Glucose Clamp Study of Wockhardt's Insulin Human Regular for Injection and Novolin R, in Healthy Subjects.CompletedNCT00596063Phase 1
- Flexible, Intensive Insulin Therapy in Patients With Type 1 DiabetesCompletedNCT00595569
- Efficacy and Safety of Insulin Detemir in Type 1 DiabetesCompletedNCT00595374Phase 3
- Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 DiabetesCompletedNCT00593255Phase 4
- Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 DiabetesCompletedNCT00592969Phase 4
- Safety and Efficacy of Insulin Detemir in Combination With OADs in Type 2 DiabetesCompletedNCT00592527Phase 3
- Self Operating of the ADI Insulin Pump By Intended Users - A Usability StudyCompletedNCT00592241Not applicable
- The Impact of Pancreatic Islet Cell Allotransplantation on Cognitive Function in Type 1 Diabetes MellitusCompletedNCT00590876
- Gender Differences in Prevalence of Undiagnosed Diabetes in ACSCompletedNCT00589459
- Imaging Inflammation in Autoimmune DiabetesCompletedNCT00585936
- Investigation Into the Effects Upon Brain Response to Change in Circulating Glucose Levels in Diabetes MellitusCompletedNCT00580710
- Vascular Risk Progression in Normal and Diabetic Control Subjects.CompletedNCT00579228
- Exenatide Pregnancy Registry - Type 2 Diabetes in PregnancyTerminatedNCT00579150
- Extension to Study HMR1964A/3011 in BelgiumCompletedNCT00576862Phase 4
- An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical PracticeCompletedNCT00576368Phase 4
- Placebo and Active Comparator Controlled Dose Response Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00575874Phase 2
- Placebo Controlled Dose-Response Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00575471Phase 2
- Nippon Ultra-Rapid Insulin and Diabetic Complication Evaluation-Study (NICE-Study)CompletedNCT00575172
- Metabolic Causes of Thrombosis in Type 2 Diabetes - Question 1CompletedNCT00574665Not applicable
- Effects of Cilostazol on Plasma Adipocytokine and Arterial StiffnessStatus unknownNCT00573950Phase 4
- Far Infrared Radiation Treatment for DiabetesStatus unknownNCT00573456Phase 1
- Initiation of Insulin Aspart in Type 2 DiabetesCompletedNCT00572806Phase 4
- Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational DiabetesWithdrawnNCT00572689Phase 4
- Comparison of Glycemic Control Achieved With 2 Different NeedlesCompletedNCT00572052Phase 4
- Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 DiabetesCompletedNCT00571935Phase 4
- Effect of Thiazolidinedione Treatment Vascular Risk MarkersCompletedNCT00571506Phase 4
- Computer Based Intervention for Type 2 Diabetes in YouthCompletedNCT00570466Not applicable
- Relation of White Blood Cell Function to DiabetesCompletedNCT00570154
- Nutritional Prevention Pilot Trial for Type 1 DiabetesCompletedNCT00570102Phase 2
- Comparison of Two Pen Systems in Patients With Diabetes Treated With InsulinCompletedNCT00569998Phase 3
- Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes PatientsCompletedNCT00569959Not applicable
- Effect of Care Management on Diabetes OutcomesCompletedNCT00569556Not applicable
- Evaluating the Use of Two Different Needles in Subjects With DiabetesCompletedNCT00569426Phase 4
- Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 DiabetesCompletedNCT00569400Phase 3
- Efficacy and Safety of Repaglinide and Metformin Combined in Type 2 DiabetesCompletedNCT00568984Phase 4
- The Role of the Duodenum in the Pathogenesis of Insulin Resistance and Type 2 Diabetes MellitusCompletedNCT00568620Not applicable
- Efficacy and Safety of Repaglinide, Glurenorm® and Glucobay® in Chinese Subjects With Type 2 DiabetesCompletedNCT00568074Phase 4
- Effect of Green Tea Extract on Type 2 DiabetesCompletedNCT00567905Phase 2/3
- Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 DiabetesCompletedNCT00567775Phase 2
- School Centered Telemedicine Program for Children With Type 1 Diabetes MellitusCompletedNCT00566475Not applicable
- Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal ExclusionCompletedNCT00566358Phase 1/2
- New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade ICompletedNCT00566189Phase 2/3
- Insulin Glargine, INITIATE Metabolic and Economic Outcomes of LantusCompletedNCT00565162Phase 4
- Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 DiabetesCompletedNCT00564668Phase 3
- 20 Week Bridging Study in Type II DMCompletedNCT00563225Phase 3
- The Effect of DBcare, a Food Supplement on Diabetes ControlCompletedNCT00563004Not applicable
- Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 DiabetesCompletedNCT00562133Phase 3
- Study of Duodenal-Jejunal Bypass(DJB) as a Potential Cure for Type 2 Diabetes MellitusCompletedNCT00562029Not applicable
- A Study to Compare the Safety and Drug Levels in Blood When Using Various Forms of GSK189075 Given to Healthy SubjectsCompletedNCT00559884Phase 1
- Study of Alagebrium in Patients With Insulin-Dependent Type 1 Diabetes and MicroalbuminuriaTerminatedNCT00557518Phase 2
- Self-care Behaviour Treatment in Patients With Diabetes - a Randomised Controlled TrialCompletedNCT00555854Not applicable
- Diabetes Mellitus Type II and Tissue OxygenationTerminatedNCT00554697
- Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 DiabetesCompletedNCT00553020Phase 4
- Comparison of Coronary Xience V and the Cypher Select+ Stents in Diabetic PatientsCompletedNCT00552994Not applicable
- Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart DiseaseStatus unknownNCT00552903Phase 3
- Improved Glycemic Control in Adult Subjects With Type 1 Diabetes on MDI Using Insulin Guidance SoftwareCompletedNCT00552734
- Isoprostane/FMD Study The Effect of Protein Kinase C (PKC) β Specific Inhibitor LY333531 on Oxidant Stress in Patients With Type 2 Diabetes MellitusCompletedNCT00552227Phase 1
- Effect of Sitagliptin on Incretin Effect in Patients With Type 2 Diabetes MellitusCompletedNCT00551590Phase 1
- Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone MaleateCompletedNCT00551564Phase 1
- Lispro Mix 25 vs. Glargine in Type 2 DiabeticsCompletedNCT00551356Phase 3
- Gestational Diabetes Mellitus and Implications for Cardiovascular Disease RiskStatus unknownNCT00550979
- To Assess the Effects of Valsartan on Albuminuria/Proteinuria in Hypertensive Patients With Type 2 Diabetes MellitusCompletedNCT00550095Phase 4
- Effect of Rosiglitazone on Myocardial Blood Flow Regulation in Type 2 DiabetesCompletedNCT00549874Not applicable
- Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing AtenololCompletedNCT00549133Phase 4
- Paleolithic Diets vs T2D and Improvements in the Metabolic SyndromeCompletedNCT00548782Not applicable
- The STATIN CHOICE Decision Aid for Type 2 Diabetes PatientsCompletedNCT00548639Not applicable
- Effect of Pioglitazone Therapy for Type 2 Diabetes on VisionCompletedNCT00548158
- The TANTALUS® II System for the Treatment of Type 2 Diabetes: A Randomized StudyTerminatedNCT00547482Not applicable
- Promoting Physical Activity Among Patients With Type 2 DiabetesCompletedNCT00547027Phase 2/3
- Glulisine + Lantus in Type I PatientsCompletedNCT00546702Phase 3
- REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic AgentsCompletedNCT00546325Phase 3
- Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes MellitusCompletedNCT00545857Phase 1